Researchers at IDWeek 2015 discussed the logistics of delivering antiretroviral therapy to all 37 million people living with HIV in the world and how to reach people during acute HIV infection.
What are the hottest developments in HIV clinical science over the past year? Physician-researcher Adaora Adimora, M.D., M.P.H., brought us a brief tour of key highlights at the start of the IDWeek 2015 medical conference in San Diego.
An all-female group of patients might respond slightly differently to HIV treatment regimens than a mostly male population, according to the Women AntiretroViral Efficacy and Safety (WAVES) study.
A poor socioeconomic score -- largely driven by financial difficulties -- independently doubled chances that HIV-positive adults in France would have a detectable viral load.
Many new HIV drugs are in development, both in existing classes and in new classes, but here are the five that are furthest along in clinical development.
In the last two decades, antiretroviral therapy has dramatically improved the health of people living with HIV. Let’s take a brief look at the past and present before we look forward to HIV treatment in 2020.
Today, new classes of antiretrovirals, such as attachment inhibitors, continue to be developed, and synthetic versions of naturally occurring antibodies -- broadly neutralizing antibodies -- are being studied for both HIV treatment and prevention....
If you want to fight the HIV epidemic, you have to put your money where your mouth is.
Looking back on how far we have come, Julio Montaner, M.D., director of the British Columbia Centre for Excellence in HIV/AIDS says we now have the "irrefutable, conclusive, impeccable" proof that starting HIV treatment immediately after testing posi...
Here's a recap of some promising news about novel HIV drugs coming through the pipeline for people with HIV, a new version of an existing drug that improves safety without compromising effectiveness, and a potential new use for an existing medication...